S. Radka

发表

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

Keith Bowman, B. Polisky, L. Jeffs, 2005, Nature Biotechnology.

Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma.

R. Law, S. Radka, P. Chandrasoma, 1994, The American journal of pathology.

Purification and identification of brain-derived neurotrophic factor from human serum.

S. Radka, A. Welcher, M. Haniu, 1995, Protein expression and purification.

Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay

S. Radka, C. Altar, Patricia A. Hoist, 1996, Brain Research.

Modulation of MHC class II expression in human cells by dexamethasone.

Santa Jeremy Ono, S. Radka, R. Schleimer, 1995, Cellular immunology.

A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors

E. Borden, J. Cowens, R. Ganapathi, 2005, Molecular Cancer Therapeutics.

Macrophage-derived factors increase low density lipoprotein uptake and receptor number in cultured human liver cells.

P. Kiener, G. Warr, C. Mazzucco, 1991, Journal of lipid research.

L cells expressing DQ molecules of the DR3 and DR4 haplotypes: reactivity patterns with mAbs

Santa Jeremy Ono, D. Monos, J. Strominger, 2004, Immunogenetics.

A monoclonal antibody directed against the HLA-Bw6 epitope.

D. B. Amos, S. Radka, D. Kostyu, 1982, Journal of immunology.

HLA-DQw3.2 allele of the DR4 haplotype is associated with insulin-dependent diabetes; correlation between DQβ restriction fragments and DQβ chain variation

R. Spielman, D. Monos, S. Radka, 2004, Immunogenetics.

Alternative splicing of HLA-DQB transcripts and secretion of HLA-DQ beta-chain proteins: allelic polymorphism in splicing and polyadenylylation sites.

J. S. Lee, S. Radka, P. Briata, 1989, Proceedings of the National Academy of Sciences of the United States of America.

The development of a monoclonal antibody specific for a 2(')-C-allyl modification of uridine, and its use in the localization of ribozymes in vivo.

L. Beigelman, S. Radka, P. Haeberli, 2002, Analytical biochemistry.

HLA-DR7-Specific monoclonal antibodies and a chimpanzee anti-DR7 serum detect different epitopes on the same molecule

P. Cresswell, S. Radka, L. J. Quackenbush, 2004, Immunogenetics.

Analysis of monoclonal antibodies reactive with human class II beta chains by two-dimensional electrophoresis and Western blotting.

P. Cresswell, C. Machamer, S. Radka, 1984, Human immunology.

Monosomy 6 in a human lymphoma line induced by selection with a monoclonal antibody.

C. Fonatsch, S. Radka, A. Ziegler, 1985, Immunobiology.

Equine class II MHC antigens: identification of two sets of epitopes using anti-human monoclonal antibodies.

D. Monos, S. Radka, M. Kamoun, 1989, Tissue Antigens.

Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells.

P. Linsley, S. Nakamura, O. Martínez-Maza, 1992, Science.

HLA-DQ alpha polymorphisms: oligonucleotide probes characterize the contribution of first and second domains to electrophoretic variants.

J. Johnston, S. Radka, B. Nepom, 1989, Human immunology.

Class II molecules of the major histocompatibility complex considered as differentiation markers.

F. Brodsky, S. Radka, D. Charron, 1986, Human immunology.

Analysis of HLA-DQ molecules with a monoclonal antibody detecting a DQ polymorphism absent from DQW1 homozygous cells.

S. Radka, S. Stewart, S. Smith, 1985, Human immunology.

J. Johnston, S. Radka, K. Nelson, 1989, Human immunology.

Monoclonal antibodies to human major histocompatibility complex class II antigens.

S. Radka, 1987, Critical reviews in immunology.

Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis.

J. Hansen, G. Nepom, W. Kwok, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Abrogation of the antiproliferative activity of oncostatin M by a monoclonal antibody.

S. Radka, J. Naemura, M. Shoyab, 1992, Cytokine.

Molecular complexity of HLA-DQw3: the TA10 determinant is located on a subset of DQw3 beta chains.

S. Radka, S. Stewart, R. Scott, 1987, Human immunology.

Expression of HLA-A and -B antigens on differentiating U-937 cells.

P. Wernet, D. Martin, S. Radka, 2008, Tissue antigens.

Regulatory role of monomorphic and polymorphic determinants of HLA class I antigens in the proliferation of T cells stimulated by autologous and allogeneic B and T lymphoid cells.

S. Ferrone, D. Santoli, S. Radka, 1988, Cellular immunology.

Biochemical Analysis of DQ α Polymorphisms Defined by a Monoclonal Antibody

J. Johnston, S. Radka, B. Nepom, 1989 .

SFR3-DR5, a monoclonal antibody with HLA-DR5 specificity.

P. Cresswell, D. B. Amos, C. Machamer, 1983, Journal of immunology.

Nonrandom association of cellular antigens with HTLV-III virions.

J. Hoxie, S. Radka, T. Fitzharris, 1987, Human immunology.

Detection of mycoplasma contamination lymphoblastoid cell lines by monoclonal antibodies.

S. Radka, R. Bolhuis, A. Polak-Vogelzang, 1984, Human immunology.

Relationship of serum levels of oncostatin M to AIDS-related and classic Kaposi's sarcoma.

L. Bernstein, R. Ross, S. Radka, 1994, Journal of Acquired Immune Deficiency Syndromes.

Correlation of oncostatin M secretion by human retrovirus-infected cells with potent growth stimulation of cultured spindle cells from AIDS-Kaposi's sarcoma.

S. Nakamura, S. Sakurada, S. Salahuddin, 1993, Journal of immunology.

Mapping of distinct serologic and T cell recognition epitopes on an HLA-DR beta-chain.

J. Gorski, S. Radka, E. Mickelson, 1990, Journal of immunology.

Characterization of specific HLA-DQ alpha allospecificities by genomic, biochemical, and serologic analysis.

S. Holbeck, G. Nepom, S. Radka, 1987, Journal of immunology.

The binding pattern of a neutralizing monoclonal antibody to mutant oncostatin M molecules is correlated with functional activity.

P. Linsley, S. Radka, M. Shoyab, 1994, Cytokine.

Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.

R. Winchester, K. Horibe, S. Radka, 1986, Journal of immunology.

Oncostatin M up-regulates low density lipoprotein receptors in HepG2 cells by a novel mechanism.

P. Kiener, C. Mazzucco, R. Grove, 1991, Journal of Biological Chemistry.

Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.

S. Ferrone, D. Santoli, S. Radka, 1986, Journal of Immunology.

Biochemical and Genomic Characterization of HLA-DQ Gene Products Associated with DR3, DR4, and DR5 Haplotypes

R. Spielman, D. Monos, S. Radka, 1989 .

Subunit and Spatial Relationships of HLA-DQ Polymorphisms That Subdivide the DQw3 Specificity

J. Johnston, S. Radka, K. Nelson, 1989 .